Cargando…

“To die is better than to tell”: reasons for and against disclosure of chronic hepatitis B status in Ghana

BACKGROUND: People with a condition subject to stigmatisation, such as chronic hepatitis B, face the dilemma of whether or not to disclose their status. In Ghana, 12.3% of the adult population has the hepatitis B virus (HBV). One key strategy for breaking the cycle of hepatitis B transmission is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Adjei, Charles Ampong, Stutterheim, Sarah E., Naab, Florence, Ruiter, Robert A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216649/
https://www.ncbi.nlm.nih.gov/pubmed/32398150
http://dx.doi.org/10.1186/s12889-020-08811-5
_version_ 1783532455590887424
author Adjei, Charles Ampong
Stutterheim, Sarah E.
Naab, Florence
Ruiter, Robert A. C.
author_facet Adjei, Charles Ampong
Stutterheim, Sarah E.
Naab, Florence
Ruiter, Robert A. C.
author_sort Adjei, Charles Ampong
collection PubMed
description BACKGROUND: People with a condition subject to stigmatisation, such as chronic hepatitis B, face the dilemma of whether or not to disclose their status. In Ghana, 12.3% of the adult population has the hepatitis B virus (HBV). One key strategy for breaking the cycle of hepatitis B transmission is the disclosure of hepatitis B status by people with chronic hepatitis B (PWHB). Disclosure can facilitate preventive actions to reduce hepatitis B transmission (e.g., not sharing personal items and avoiding contact with blood and body fluids). Disclosure can also motivate family members of PWHB to get tested, linked to care and clinically managed in order to reduce the progression of hepatitis B to liver cirrhosis and cancer. Given the importance of disclosure, we set out to explore reasons for and against disclosure of chronic hepatitis B status in the Greater Accra and Upper East region of Ghana. METHODS: In this exploratory qualitative study, 18 participants (10 from the Greater Accra region and 8 from the Upper East region) were recruited for semi-structured interviews. Interviews were recorded and transcribed verbatim. Data were then processed using QSR Nvivo version 10.0 and analysed for themes. RESULTS: Participants were selective disclosers, disclosing in some contexts and not in others. Reasons for non-disclosure of chronic hepatitis B status were: 1) fear of stigmatisation and 2) previous negative experiences with disclosure. Reasons for disclosure were: 1) wanting close contacts to get tested or vaccinated, 2) trusting the disclosure target(s), and 3) needing social and/or financial support. CONCLUSIONS: Our findings highlight various reasons for and against disclosure of chronic hepatitis B status in Ghana. Because anticipated, observed, and experienced stigma were important motivations for non-disclosure of chronic hepatitis B status, we recommend the development and implementation of theory and evidence-based stigma reduction interventions that are culturally appropriate, and that prioritize the participation of target populations. We also recommend the provision of counselling and support services that assist PWHB in their disclosure decision-making processes.
format Online
Article
Text
id pubmed-7216649
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72166492020-05-18 “To die is better than to tell”: reasons for and against disclosure of chronic hepatitis B status in Ghana Adjei, Charles Ampong Stutterheim, Sarah E. Naab, Florence Ruiter, Robert A. C. BMC Public Health Research Article BACKGROUND: People with a condition subject to stigmatisation, such as chronic hepatitis B, face the dilemma of whether or not to disclose their status. In Ghana, 12.3% of the adult population has the hepatitis B virus (HBV). One key strategy for breaking the cycle of hepatitis B transmission is the disclosure of hepatitis B status by people with chronic hepatitis B (PWHB). Disclosure can facilitate preventive actions to reduce hepatitis B transmission (e.g., not sharing personal items and avoiding contact with blood and body fluids). Disclosure can also motivate family members of PWHB to get tested, linked to care and clinically managed in order to reduce the progression of hepatitis B to liver cirrhosis and cancer. Given the importance of disclosure, we set out to explore reasons for and against disclosure of chronic hepatitis B status in the Greater Accra and Upper East region of Ghana. METHODS: In this exploratory qualitative study, 18 participants (10 from the Greater Accra region and 8 from the Upper East region) were recruited for semi-structured interviews. Interviews were recorded and transcribed verbatim. Data were then processed using QSR Nvivo version 10.0 and analysed for themes. RESULTS: Participants were selective disclosers, disclosing in some contexts and not in others. Reasons for non-disclosure of chronic hepatitis B status were: 1) fear of stigmatisation and 2) previous negative experiences with disclosure. Reasons for disclosure were: 1) wanting close contacts to get tested or vaccinated, 2) trusting the disclosure target(s), and 3) needing social and/or financial support. CONCLUSIONS: Our findings highlight various reasons for and against disclosure of chronic hepatitis B status in Ghana. Because anticipated, observed, and experienced stigma were important motivations for non-disclosure of chronic hepatitis B status, we recommend the development and implementation of theory and evidence-based stigma reduction interventions that are culturally appropriate, and that prioritize the participation of target populations. We also recommend the provision of counselling and support services that assist PWHB in their disclosure decision-making processes. BioMed Central 2020-05-12 /pmc/articles/PMC7216649/ /pubmed/32398150 http://dx.doi.org/10.1186/s12889-020-08811-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Adjei, Charles Ampong
Stutterheim, Sarah E.
Naab, Florence
Ruiter, Robert A. C.
“To die is better than to tell”: reasons for and against disclosure of chronic hepatitis B status in Ghana
title “To die is better than to tell”: reasons for and against disclosure of chronic hepatitis B status in Ghana
title_full “To die is better than to tell”: reasons for and against disclosure of chronic hepatitis B status in Ghana
title_fullStr “To die is better than to tell”: reasons for and against disclosure of chronic hepatitis B status in Ghana
title_full_unstemmed “To die is better than to tell”: reasons for and against disclosure of chronic hepatitis B status in Ghana
title_short “To die is better than to tell”: reasons for and against disclosure of chronic hepatitis B status in Ghana
title_sort “to die is better than to tell”: reasons for and against disclosure of chronic hepatitis b status in ghana
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216649/
https://www.ncbi.nlm.nih.gov/pubmed/32398150
http://dx.doi.org/10.1186/s12889-020-08811-5
work_keys_str_mv AT adjeicharlesampong todieisbetterthantotellreasonsforandagainstdisclosureofchronichepatitisbstatusinghana
AT stutterheimsarahe todieisbetterthantotellreasonsforandagainstdisclosureofchronichepatitisbstatusinghana
AT naabflorence todieisbetterthantotellreasonsforandagainstdisclosureofchronichepatitisbstatusinghana
AT ruiterrobertac todieisbetterthantotellreasonsforandagainstdisclosureofchronichepatitisbstatusinghana